Higher Frequency and Mortality Rate of Antimicrobial-resistant Bloodstream Infections in Tertiary-care Hospitals Compared with Secondary-care Hospitals in Thailand

Author:

Lim CherryORCID,Hantrakun Viriya,Klaytong Preeyarach,Rangsiwutisak Chalida,Tangwangvivat Ratanaporn,phiancharoen Chadaporn,Doung-ngern PawineeORCID,Kripattanapong Somkid,Hinjoy Soawapak,Yingyong Thitipong,Rojanawiwat Archawin,Unahalekhaka Aekkawat,Kamjumphol Watcharaporn,Khobanan Kulsumpun,Leethongdee Phimrata,Lorchirachoonkul Narisorn,Khusuwan Suwimon,Siriboon Suwatthiya,Chamnan ParinyaORCID,Vijitleela Amornrat,Fongthong Traithep,Noiprapai Krittiya,Boonyarit Phairam,Srisuphan Voranadda,Sartorius Benn,Stelling John,Turner PaulORCID,Day Nicholas PJ,Limmathurotsakul DirekORCID

Abstract

AbstractThere are few studies comparing proportion, frequency, mortality and mortality rate of antimicrobial-resistant (AMR) bacterial infections between tertiary-care hospitals (TCHs) and secondary-care hospitals (SCHs) in low and middle-income countries (LMICs) to inform infection control strategies. We evaluated bloodstream infections (BSIs) from 2012 to 2015 in 15 TCHs and 34 SCHs in Thailand. There were differences in the proportions (%) of BSI caused by AMR strains for some pathogens between TCHs and SCHs. Of 19,665 patients with AMR BSI, 6,746 (34.3%) died. Among patients with AMR BSI, there were no or minimal differences in mortality proportion for all AMR pathogens between TCHs and SCHs. However, the frequency and mortality rates of AMR BSI were considerably higher in TCHs for most pathogens. For example, the mortality rate of hospital-origin carbapenem-resistantAcinetobacter baumanniiBSI in TCHs was nearly three times higher than that in SCHs (10.2 vs. 3.6 per 100,000 patient-days at risk, mortality rate ratio 2.77; 95% confidence interval 1.71 to 4.48, p<0.0001). Targets of and resources for antimicrobial stewardship and infection control programs in LMICs may need to be tailored based on hospital type and size, as burden of AMR infections could differ by hospital setting.

Publisher

Cold Spring Harbor Laboratory

Reference36 articles.

1. The Review on Antimicrobial Resistance. Tackling Drug-resistant Infections Globally: Final Report and Recommendation, 2016 (accessed on 19 Nov 2022).

2. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis;Antimicrobial Resistance Collaborators;Lancet,2022

3. World Health Organization. Global antimicrobial resistance and use surveillance systems. 2021. https://www.who.int/data/gho/data/themes/topics/global-antimicrobial-resistance-surveillance-system-glass/glass-country-profiles (accessed on 19 Nov 2022).

4. World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2021. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO (accessed on 19 Nov 2022).

5. World Health Organization. Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early implementation 2017-2018, 2018 (accessed on 19 Nov 2022).

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3